| European Case Law Identifier: | ECLI:EP:BA:2017:T188913.20170314 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 March 2017 | ||||||||
| Case number: | T 1889/13 | ||||||||
| Application number: | 02790278.2 | ||||||||
| IPC class: | A61L 24/10 A61L 24/04 B01F 13/00 B01F 15/02 B65D 25/08 A61K 9/00 B01F 3/12 A61L 33/12 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | A HEMOSTATIC KIT, A METHOD OF PREPARING A HEMOSTATIC AGENT AND A METHOD OF PROMOTING HEMOSTASIS | ||||||||
| Applicant name: | Ferrosan Medical Devices A/S | ||||||||
| Opponent name: | Baxter Innovations GmbH | ||||||||
| Board: | 3.3.10 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | "Partiality of two board members (no)" | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131889eu2.html
Date retrieved: 17 May 2021